Evidence map›Paper›PMID 34012579›Full record

ArticleJournal of thoracic disease2021

Epidemiology and clinical features of common community human coronavirus disease.

Taehee Kim, Hayoung Choi, Tae Rim Shin, Yousang Ko, Yong Bum Park, Hwan Il Kim, Seung Hun Jang, Ki Suck Jung, Youlim Kim, Myung Goo Lee and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of thoracic disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Taehee KimDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.
Hayoung ChoiDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.
Tae Rim ShinDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.
Yousang KoLung Research Institute, Hallym University College of Medicine, Chuncheon-si, Gangwon-do, Republic of Korea.
Yong Bum ParkLung Research Institute, Hallym University College of Medicine, Chuncheon-si, Gangwon-do, Republic of Korea.
Hwan Il KimLung Research Institute, Hallym University College of Medicine, Chuncheon-si, Gangwon-do, Republic of Korea.
Seung Hun JangLung Research Institute, Hallym University College of Medicine, Chuncheon-si, Gangwon-do, Republic of Korea.
Ki Suck JungLung Research Institute, Hallym University College of Medicine, Chuncheon-si, Gangwon-do, Republic of Korea.
Youlim KimLung Research Institute, Hallym University College of Medicine, Chuncheon-si, Gangwon-do, Republic of Korea.
Myung Goo LeeLung Research Institute, Hallym University College of Medicine, Chuncheon-si, Gangwon-do, Republic of Korea.
Soojie ChungLung Research Institute, Hallym University College of Medicine, Chuncheon-si, Gangwon-do, Republic of Korea.
Cheol-Hong KimLung Research Institute, Hallym University College of Medicine, Chuncheon-si, Gangwon-do, Republic of Korea.
In Gyu HyunLung Research Institute, Hallym University College of Medicine, Chuncheon-si, Gangwon-do, Republic of Korea.
Yun Su SimDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.
Hallym University · KRHallym University Chuncheon Sacred Heart Hospital · KRKangdong Sacred Heart Hospital · KRHallym University Kangnam Sacred Heart Hospital · KRHallym University Sacred Heart Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe would evaluate the epidemiology, clinical aspects, and prognostic factors of patients of all ages admitted with human corona virus (HCoV).

methodsThis study was retrospectively performed at five university teaching hospitals between 1st January 2018 and 31th March 2020. Routine molecular testing using for multiplex real-time reverse transcription-polymerase chain reaction (RT-PCR) methods was conducted on the respiratory viruses. We assessed the demographics, laboratory findings, and treatment of patients infected with coronavirus.

resultsThere were 807 coronavirus-infected patients from 24,311 patients with respiratory virus PCR test admitted to five hospitals over 27 months. All-cause mortality rates of patients admitted for seasonal HCoV disease were 3.1% in all patients and 10.8% in patients aged ≥18 years. The Cox proportional hazard regression analysis was performed in patients aged ≥18 years. After adjusting for other clinical variables, general weakness symptoms [hazard ratio (HR), 2.651; 95% confidence interval (CI), 1.147-6.125, P=0.023], National Early Warning Score (NEWS) ≥2 (HR, 5.485; 95% CI, 1.261-23.858, P=0.023), and coronavirus subtype OC43 (HR, 2.500; 95% CI, 1.060-5.897, P=0.036) were significantly associated with death from coronavirus.

conclusionsCoronavirus infection can reveal a higher mortality rate in patients of ≥18 than those of <18 years, thus, adult patients require more careful treatment. Furthermore, in adult patients, the factors associated with death from coronavirus include general weakness symptoms, NEWS higher than 2, and OC43 subtype.

Indexed as

Coronavirusmortalityviral disease

Identifiers

PMID34012579
PMCPMC8107519
OpenAlexW3148011746

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.